Kiora Pharmaceuticals (KPRX) Net Equity Issued and Repurchased (2014 - 2026)
Kiora Pharmaceuticals' Net Equity Issued and Repurchased came in at $5 million for Q2 2026, compared with $265,359 a year earlier.
Powered by 
Analysis
Kiora Pharmaceuticals (KPRX) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
For FY2025, Kiora Pharmaceuticals' Net Equity Issued and Repurchased was $265,655, down 98.2% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -44.4% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $15 million in FY2024, $307,079 in FY2023 (-88.8%), $2.74 million in FY2022 (-84.6%) and $17.75 million in FY2021 (+254.9%).
- The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Kiora Pharmaceuticals | 8.53 Mn | -58.79 Mn | - | 5.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 170.00 |
| Dec 31, 2025 | 296.00 |
| Jun 30, 2025 | 265,359.00 |
| Jun 30, 2024 | 249,387.00 |
| Mar 31, 2024 | 16.44 Mn |
| Dec 31, 2023 | -465,438.00 |
| Sep 30, 2023 | 4,818.00 |
| Jun 30, 2023 | 642,310.00 |
| Mar 31, 2023 | 298,500.00 |
| Dec 31, 2022 | 3.26 Mn |
| Sep 30, 2022 | 1,600.00 |
| Mar 31, 2021 | 8.04 Mn |
| Dec 31, 2020 | 716,687.00 |
| Mar 31, 2020 | 4.50 Mn |
| Dec 31, 2019 | 3.99 Mn |
| Jun 30, 2019 | 32,000.00 |
| Dec 31, 2018 | 187,029.00 |
| Sep 30, 2018 | 308,322.00 |
| Jun 30, 2018 | 10.86 Mn |
API Access
Kiora Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "KPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();